(4'-Hydroxy-[1,1'-biphenyl]-4-yl)(piperidin-1-yl)methanone

Catalog No.: 
ACKCFO521
CAS No.: 
1125430-43-4
Molecular Formula: 
C18H19NO2
Molecular Weight: 
281.36
(4'-Hydroxy-[1,1'-biphenyl]-4-yl)(piperidin-1-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$70.00InquiryInquiry
1g98%$167.00InquiryInquiry
5g98%$498.00InquiryInquiry
10g98%$829.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4'-Hydroxy-[1,1'-biphenyl]-4-yl)(piperidin-1-yl)methanone
IUPAC Name(4'-hydroxy-[1,1'-biphenyl]-4-yl)(piperidin-1-yl)methanone
MDL No.MFCD18313045
Molecular FormulaC18H19NO2
Molecular Weight281.36
SMILESO=C(C1=CC=C(C2=CC=C(O)C=C2)C=C1)N3CCCCC3
InChI KeyQOQODQYWGUOWCJ-UHFFFAOYSA-N
Synonym4-[4-(Piperidine-1-carbonyl)phenyl]phenol;(4'-Hydroxy-[1,1'-biphenyl]-4-yl)(piperidin-1-yl)methanone;Methanone, (4'-hydroxy[1,1'-biphenyl]-4-yl)-1-piperidinyl-;(4'-Hydroxy[1,1'-biphenyl]-4-yl)-1-piperidinylmethanone
CAS No.1125430-43-4

Synthetic Route by SureRoute

1. ACKCFO521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACORPT427 route compound structure diagram
    ACORPT42758574-03-1In Stock
  4. Then
  5. ACKCFO521 route product structure diagram
    ACKCFO5211125430-43-4
Inquiry

2. ACKCFO521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMSHU394 route compound structure diagram
    ACMSHU39471597-85-8In Stock
  4. Then
  5. ACKCFO521 route product structure diagram
    ACKCFO5211125430-43-4
Inquiry

3. ACKCFO521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKCFO521 route product structure diagram
    ACKCFO5211125430-43-4
Inquiry

Comments (0)